TKPHF - Takeda Pharmaceutical Company Limited's (TAK) CEO Christophe Weber on Q4 2020 Results - Earnings Call Transcript
Takeda Pharmaceutical Company Limited (TAK) Q4 2020 Earnings Conference Call May 11, 2021, 8:00 am ET Company Participants Christopher O'Reilly - Global Head, IR Christophe Weber - President & CEO Andy Plump - President, R&D Costa Saroukos - CFO Ramona Sequeira - President, U.S. Business Unit & Global Portfolio Commercialization Julie Kim - President, Plasma-Derived Therapies Business Unit Conference Call Participants Shinichiro Muraoka - Morgan Stanley MUFG Ken Cacciatore - Cowen Hidemaru Yamaguchi - Citigroup Trevor Polischuk - OrbiMed Presentation Operator Good day everyone, and welcome to the conference call of Takeda Pharmaceutical Company Limited. During the presentation from the company, all the telephone lines are placed for listening-mode only. And the question-and-answer session will be held after the presentation. Now we'll start the conference. Mr. O'Reilly, please go ahead. Christopher O'Reilly Hello, good morning, good afternoon, good evening. My name is Christopher O'Reilly, Global Head of Investor Relations. Thank
For further details see:
Takeda Pharmaceutical Company Limited's (TAK) CEO Christophe Weber on Q4 2020 Results - Earnings Call Transcript